NCT02117245View on ClinicalTrials.gov

Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Trial Locations (1)

Unknown

Algorithme, Laval

Sponsors
All Listed Sponsors
lead

Mirati Therapeutics Inc.

INDUSTRY

NCT02117245 - Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers | Biotech Hunter | Biotech Hunter